KDnuggets : News : 2004 : n23 : item25 < PREVIOUS | NEXT >

Briefs

Glaxosmithkline Selects Inforsense Technology For Cheminformatics Infrastructure

InforSense to provide GSK with next generation integrated discovery platform

London, UK, 30 November 2004 - InforSense Ltd., the leader in Open Discovery Workflow(tm) informatics platforms, today announced that GlaxoSmithKline (GSK) Cheminformatics has licensed InforSense technology to provide an innovative workflow-based decision support environment for discovery scientists. GSK's goal in collaboration with InforSense, is to establish and deploy the "next generation" flexible, user-friendly informatics environment to scientists. This environment will allow them to capture, standardize and accelerate decision-making across their Discovery Research organization.

"Our scientists have to deal with growing quantities of data. The more efficient we are at processing these data, the better will be our decision making. The challenge is both to facilitate this dynamic and iterative process and at the same time capture the key decisions that are made so they can be improved over time," commented Stephen Calvert, Vice President, Cheminformatics at GSK. "An organization like GSK must also ensure that the IT infrastructure we build is both scalable and maintainable. InforSense workflow technology provides a scalable integration solution, enabling our scientists to develop, enhance and share discovery services. With InforSense we will ensure that the technology we build our infrastructure upon is an industry standard."

For further information, visit www.inforsense.com.


KDnuggets : News : 2004 : n23 : item25 < PREVIOUS | NEXT >

Copyright © 2004 KDnuggets.   Subscribe to KDnuggets News!